Fig. 6From: Tumor buster - where will the CAR-T cell therapy ‘missile’ go?The strategies used to deal with the lack of ideal antigen or loss of antigen. iCAR: inhibitory CAR; DNR: dominant negative receptor; CSR: chimeric-switch receptor; FAP: fibroblast activation protein; VEGFR: vascular endothelial growth factor receptor; CAF: Cancer-associated fibroblastBack to article page